Source: Annual Congress 2005 - Various aspects of pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. C. Seyhan, E. Cetinkaya, S. Altin, G. Safak, E. Kucukates, S. Timur (Istanbul, Turkey). The role of hepatitis C virus infections in idiopathic pulmonary fibrosis. Eur Respir J 2005; 26: Suppl. 49, 2187

Member's Comments

No comment yet.

Related content which might interest you: Interstitial lung involvement in patients with chronic HCV hepatitis Source: Eur Respir J 2006; 28: Suppl. 50, 744s Year: 2006 Clinical-evolutive aspects of pulmonary tuberculosis at patients with chronic hepatitis Source: Annual Congress 2007 - Tuberculosis Year: 2007 Epstein-Barr virus specific antibodies in patients with idiopathic pulmonary fibrosis and presence of EBV in respiratory tract: reactivation of infection? Source: Eur Respir J 2005; 26: Suppl. 49, 333s Year: 2005 Prevention of drug-induced liver injury in patients with pulmonary tuberculosis and chronic hepatitis C Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019 Prevalence of hepatitis c virus infection among patients with COPD Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 The prevalence rate of chronic hepatitis B and C among pulmonary TB patients Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008 A case of acute interstitial pneumonia which developed during the interferon and ribavirin treatment for chronic hepatitis C Source: Eur Respir J 2005; 26: Suppl. 49, 84s Year: 2005 The role of viruses in the pathogenesis of pulmonary fibrosis Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease Year: 2021 Role of influenza virus infection in lung fibrosis Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Sarcoidosis associated with interferon-α therapy for chronic hepatitis C Source: Eur Respir J 2006; 28: Suppl. 50, 541s Year: 2006 Evolution of previous sarcoidosis under type 1 interferons given for severe associated disease Source: Eur Respir J 2005; 25: 570-573 Year: 2005 Pulmonary arterial hypertension in end-stage idiopathic pulmonary fibrosis: a hypothetic role for viral infections Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009 The incidence of hepatitis C virus in patients with lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 94s Year: 2006 The role of infection in the pathogenesis of idiopathic pulmonary fibrosis}, Source: Eur Respir Rev 2013; 22: 376-381 Year: 2013 Results of treatment of patients with pulmonary tuberculosis combined with HIV infection and hepatitis Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018 Association between influenza vaccination and the occurrence of acute exacerbation in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 Respiratory infections in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009 A possible role for Epstein-Barr virus infection in COPD? Source: Eur Respir J 2008; 32: 1411-1412 Year: 2008 Respiratory viral agents in cystic fibrosis Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Hepatopulmonary syndrome in non-cirrhotic patients with chronic viral hepatitis Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015